Faraone, Stephen V <br/><br/>
Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder.  [electronic resource] 

 -  Expert opinion on pharmacotherapy  Jun 2008 
 - 1565-74 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1744-7666 
<br/><br/><label>Standard No.: </label>10.1517/14656566.9.9.1565  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Attention Deficit Disorder with Hyperactivity--drug therapy<br/>Child<br/>Delayed-Action Preparations<br/>Dextroamphetamine--adverse effects<br/>Humans<br/>Lisdexamfetamine Dimesylate<br/>Prodrugs--adverse effects<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome